KCNN4 and S100A14 act as predictors of recurrence in optimally debulked patients with serous ovarian cancer

Approximately 50-75% of patients with serous ovarian carcinoma (SOC) experience recurrence within 18 months after first-line treatment. Current clinical indicators are inadequate for predicting the risk of recurrence. In this study, we used 7 publicly available microarray datasets to identify gene s...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Haiyue, Guo, Ensong, Hu, Ting, Sun, Qian, Wu, Jianli, Lin, Xingguang, Luo, Danfeng, Sun, Chaoyang, Wang, Changyu, Zhou, Bo, Li, Na, Xia, Meng, Lu, Hao, Meng, Li, Xu, Xiaoyan, Hu, Junbo, Ma, Ding, Chen, Gang, Zhu, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190068/
https://www.ncbi.nlm.nih.gov/pubmed/27270322
http://dx.doi.org/10.18632/oncotarget.9721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190068/
https://www.ncbi.nlm.nih.gov/pubmed/27270322
http://dx.doi.org/10.18632/oncotarget.9721

Ejemplares similares